Page last updated: 2024-09-03

5-s-cysteinyldopamine and Neuroblastoma

5-s-cysteinyldopamine has been researched along with Neuroblastoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aureli, C; Cassano, T; Chichiarelli, S; Cocciolo, A; d'Erme, M; Fontana, M; Francioso, A; Gaetani, S; Mancini, P; Martire, S; Masci, A; Mosca, L; Romano, A1
d'Erme, M; Lendaro, E; Marcellini, S; Moretti, S; Mosca, L; Rosei, MA1

Other Studies

2 other study(ies) available for 5-s-cysteinyldopamine and Neuroblastoma

ArticleYear
5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease.
    Journal of neuroscience research, 2014, Volume: 92, Issue:3

    Topics: alpha-Synuclein; Animals; Biogenic Monoamines; Brain; Cell Line, Tumor; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Glutathione; Glutathione Disulfide; Humans; Male; Mice; Neuroblastoma; Oxidative Stress; Oxidopamine; Parkinson Disease; Protein Carbonylation; Protein Disulfide-Isomerases

2014
5-S-Cysteinyl-dopamine effect on the human dopaminergic neuroblastoma cell line SH-SY5Y.
    Neurochemistry international, 2006, Volume: 49, Issue:3

    Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Humans; Neuroblastoma

2006